Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Parallel Group Extension Study to Determine the Safety and Efficacy of Long-Term Nebivolol Exposure in Patients With Mild to Moderate Hypertension

NCT00200499 is registered in ClinicalTrials.gov with Mylan Bertek Pharmaceuticals as lead sponsor.

NCT NCT00200499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00200499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Parallel Group Extension Study to Determine the Safety and Efficacy of Long-Term Nebivolol Exposure in Patients With Mild to Moderate Hypertension
Lead sponsor
Mylan Bertek Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2002
Completion date
September 30, 2003
Enrollment
845
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension